Chinese EV maker Nio to launch its decrease-priced brand name Onvo on May possibly 15

Chinese EV maker Nio to launch its decrease-priced brand name Onvo on May possibly 15


Nio retains a product party in Shanghai on Sept. 21, 2023.

Evelyn Cheng | CNBC

BEIJING — Chinese electric auto business Nio claimed Thursday it will start its lower-priced manufacturer termed Onvo on May well 15.

The announcement arrives amid a value war in China’s remarkably competitive electrical car or truck industry that’s forced Tesla to minimize selling prices. Xpeng, a further EV startup, also strategies to release a sub-manufacturer known as Mona in the following two or a few months.

Nio stated the initially Onvo model, the L60, will be a “loved ones-centric wise BEV priced about RMB 250,000, in the similar section as Tesla Model Y.” That’s about $34,600.

In contrast, Nio’s SUVs and sedans presently sell for virtually 300,000 yuan or significantly extra. Nio delivered 15,620 electric autos in April, up from 11,866 cars the prior month.

The firm’s CEO William Li earlier informed CNBC that the first Onvo auto will be an SUV much less expensive than the Model Y.

Nio explained Onvo stands for “On Voyage,” and that that the Chinese identify of the brand name, “Le Dao,” signifies “Path to Contentment.” The firm sells cars and trucks to Europe, but did not specify no matter whether Onvo would be readily available outside the house China.

Nio CEO: We want to keep prices of our cars stable



Resource

‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.
World

‘Draconian development’ in Meta-Manus deal draws the line in China’s AI race with the U.S.

Manus was hailed by Chinese state media as the “next DeepSeek” soon after its launch in March 2025, months before the startup relocated to Singapore. Cheng Xin | Getty Images News | Getty Images BEIJING — China’s decision to block U.S. tech giant Meta‘s $2 billion acquisition of artificial intelligence startup Manus is being seen […]

Read More
Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’
World

Novartis CEO warns reality of Trump’s drug pricing policy will set in over ‘the next 18 months’

Novartis‘ CEO warned Tuesday that the U.S. drug pricing policy under President Donald Trump poses a “very difficult situation” and the reality will soon catch up with both drugmakers and patients. “The longer-term implications are significant,” CEO Vas Narasimhan told CNBC’s Carolin Roth. Novartis is focused on getting European and Japanese governments to quickly change […]

Read More
CNBC Daily Open: Hawkish hold from BOJ sets central bank stage
World

CNBC Daily Open: Hawkish hold from BOJ sets central bank stage

The Bank of Japan headquarters in Tokyo on May 30, 2024. Kazuhiro Nogi | Afp | Getty Images Hello, this is Katie Foley writing to you from London. I spend my mornings leading the London TV teams as we prepare to take Europe Early Edition and Squawk Box Europe to air. Over the last two […]

Read More